FDA Releases Cefaly(R) for Acute Treatment of Migraine Attacks

NEW YORK, Sept. 21, 2017 -- (Healthcare Sales & Marketing Network) -- CEFALY Technology announces today that on Friday, September 15th, the U.S. Food and Drug Administration (FDA) released the use of a new Cefaly® medical device for the acute treatmen... Devices, Neurology, FDA CEFALY Technology, trigeminal nerve stimulation, e-TNS, migraine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news